share_log

HC Wainwright & Co. Maintains Buy on Purple Biotech, Lowers Price Target to $8

Benzinga ·  Sep 19 03:29  · Ratings

HC Wainwright & Co. analyst Emily Bodnar maintains Purple Biotech (NASDAQ:PPBT) with a Buy and lowers the price target from $10 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment